Neumora Therapeutics to Participate in Upcoming Conferences in November
Neumora Therapeutics (Nasdaq: NMRA) will participate in two investor conferences in November 2025. Management will take part in fireside chats at the Guggenheim 2nd Annual Healthcare Innovation Conference on Monday, November 10, 2025 at 2:30 p.m. ET in Boston and at the Stifel 2025 Healthcare Conference on Wednesday, November 12, 2025 at 2:00 p.m. ET in New York.
A live webcast of both events will be available on the company's events and presentations webpage at www.neumoratx.com, with replays archived for up to 30 days after the events.
Neumora Therapeutics (Nasdaq: NMRA) parteciperà a due conferenze per investitori a novembre 2025. La direzione interverrà in colloqui informali durante la Guggenheim 2nd Annual Healthcare Innovation Conference il lunedì 10 novembre 2025 alle 14:30 ET a Boston e alla Stifel 2025 Healthcare Conference mercoledì 12 novembre 2025 alle 14:00 ET a New York.
Una diretta streaming di entrambi gli eventi sarà disponibile sulla pagina degli eventi e delle presentazioni dell'azienda all'indirizzo www.neumoratx.com, con le repliche archiviate per un massimo di 30 giorni dopo gli eventi.
Neumora Therapeutics (Nasdaq: NMRA) participará en dos conferencias para inversores en noviembre de 2025. La dirección participará en charlas informales en la Guggenheim 2nd Annual Healthcare Innovation Conference el lunes 10 de noviembre de 2025 a las 2:30 p.m. ET en Boston y en la Stifel 2025 Healthcare Conference el miércoles 12 de noviembre de 2025 a las 2:00 p.m. ET en Nueva York.
Una transmisión en vivo de ambos eventos estará disponible en la página de eventos y presentaciones de la empresa en www.neumoratx.com, con repeticiones archivadas por hasta 30 días después de los eventos.
Neumora Therapeutics (Nasdaq: NMRA) 는 2025년 11월 두 차례의 투자자 컨퍼런스에 참여합니다. 경영진은 보스턴에서 열리는 Guggenheim 2nd Annual Healthcare Innovation Conference의 화롯대 대담에 2025년 11월 10일 월요일 오후 2:30(동부 표준시)에 참석하고 Stifel 2025 Healthcare Conference의 대담은 뉴욕에서 2025년 11월 12일 수요일 오후 2:00(동부 표준시)에 참여합니다.
두 행사 모두의 라이브 웹캐스트는 회사의 이벤트 및 프레젠테이션 페이지 www.neumoratx.com에서 이용 가능하며, 이벤트 종료 후 최대 30일 동안 다시보기가 보관됩니다.
Neumora Therapeutics (Nasdaq : NMRA) participera à deux conférences pour investisseurs en novembre 2025. La direction participera à des entretiens informels lors de la Guggenheim 2nd Annual Healthcare Innovation Conference le lundi 10 novembre 2025 à 14h30 HE à Boston et à la Stifel 2025 Healthcare Conference le mercredi 12 novembre 2025 à 14h00 HE à New York.
Une diffusion en direct des deux événements sera disponible sur la page des événements et des présentations de l’entreprise à l’adresse www.neumoratx.com, les rediffusions étant archivées jusqu’à 30 jours après les événements.
Neumora Therapeutics (NASDAQ: NMRA) wird im November 2025 an zwei Investorenkonferenzen teilnehmen. Das Management wird an Fireside Chats bei der Guggenheim 2nd Annual Healthcare Innovation Conference am Montag, 10. November 2025 um 14:30 Uhr ET in Boston teilnehmen und bei der Stifel 2025 Healthcare Conference am Mittwoch, 12. November 2025 um 14:00 Uhr ET in New York.
Eine Live-Übertragung beider Veranstaltungen ist auf der Seite des Unternehmens zu finden, auf der sich auch die Präsentationen befinden, unter www.neumoratx.com, mit Aufzeichnungen für bis zu 30 Tage nach den Veranstaltungen.
Neumora Therapeutics (Nasdaq: NMRA) ستشارك في مؤتمرين للمستثمرين في نوفمبر 2025. ستشارك الإدارة في جلسات حوار عند قمة Guggenheim السنوية الثانية للابتكار في الرعاية الصحية في الاثنين 10 نوفمبر 2025 الساعة 2:30 مساءً بتوقيت شرق الولايات المتحدة في بوسطن وكـ قمة Stifel للرعاية الصحية 2025 في الأربعاء 12 نوفمبر 2025 الساعة 2:00 مساءً بتوقيت شرق الولايات المتحدة في نيويورك.
ستتوفر بث حي لكلا الحدثين على صفحة الأحداث والعروض التقديمية للشركة على www.neumoratx.com، مع أرشفة الإعادة لمدة حتى 30 يوماً بعد الأحداث.
- None.
- None.
WATERTOWN, Mass., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Neumora Therapeutics, Inc. (Nasdaq: NMRA), a clinical-stage biopharmaceutical company with a therapeutics pipeline consisting of seven programs that target novel mechanisms of action for a broad range of underserved, prevalent diseases, today announced that the Company will participate in two investor conferences in November.
- Guggenheim 2nd Annual Healthcare Innovation Conference: Members of management will participate in a fireside chat on Monday, November 10, 2025, at 2:30 p.m. ET in Boston, MA.
- Stifel 2025 Healthcare Conference: Members of management will participate in a fireside chat on Wednesday, November 12, 2025, at 2:00 p.m. ET in New York, NY.
A live webcast of the events will be available on the events and presentations section of the Company’s website at www.neumoratx.com. A replay of the webcasts will be available following the completion of the events and will be archived for up to 30 days.
About Neumora
Neumora Therapeutics, Inc. is a clinical-stage biopharmaceutical company founded to confront the greatest medical challenges of our generation by taking a fundamentally different approach to the way treatments for brain diseases are developed. Our therapeutic pipeline currently consists of seven programs that target novel mechanisms of action for a broad range of underserved, prevalent diseases. Neumora’s mission is to redefine neuroscience drug development by bringing forward the next generation of novel therapies that offer improved treatment outcomes and quality of life for patients.
Neumora Contact:
Helen Rubinstein
617-402-5700
Helen.Rubinstein@neumoratx.com
FAQ
When will Neumora Therapeutics (NMRA) present at the Guggenheim Healthcare Innovation Conference?
When is Neumora Therapeutics (NMRA) scheduled to speak at the Stifel 2025 Healthcare Conference?
Where can investors watch the Neumora (NMRA) conference webcasts live?
Will Neumora (NMRA) provide replays of the November 2025 conference presentations?
What will Neumora (NMRA) management do at the November 2025 conferences?
Are the Neumora (NMRA) conference sessions accessible to remote investors on specific dates?
